Latest Share Chat

REMOVE ADS

Biontech Se Adr Share News (0A3M)

Biontech Se Adr Information

Share Price Information for Biontech Se Adr (0A3M)

Share Price is delayed by 15 minutes

Get Live Data

90.75 2.75 (3.13%)

Bid:

88.50

Ask:

93.00

Spread: 4.50 (5.085%)

Market Cap: $22.95b

Last checked at -

Intraday Biontech Se Adr Share Chart

This share is an international stock.

REMOVE ADS

Biontech Se Adr News

BioNTech to invest up to £1bn in UK R&D expansion

(Sharecast News) - BioNTech announced on Tuesday that it will invest up to £1bn over the next decade to expand its research and development footp...

UK approves Pfizer-BioNTech Covid-19 vaccine shot for use in 12-15 year olds

(Sharecast News) - Britain has approved the Covid-19 vaccine jointly developed by Pfizer-BioNTech for use in children ages 12 to 15.

Pfizer-BioNTech to supply EU with additional 200m doses of Covid-19 vaccine

(Sharecast News) - Pfizer and BioNTech have agreed to supply the European Union with an additional 200 million doses of their Covid-19 vaccine.

BioNTech starts Covid-19 vaccine production at new Marburg plant

(Sharecast News) - BioNTech has started production of its Covid-19 vaccine from a new manufacturing site in Marburg, Germany.

EU negotiating boost in Covid-19 doses from Pfizer/BioNTech to 600m

(Sharecast News) - Brussels is negotiating a deal with Pfizer and BioNTech to provide enough Covid-19 vaccine doses to inoculate as much as two-thirds...

China's Sinopharm seeks Covid vaccine approval at 79% effectiveness

(Sharecast News) - Chinese Covid-19 vaccine developer Sinopharm said it will seek approval from regulators after final stage trials showed a 79% effic...

WHO claims new loans and bonds could fill $28bn gap for coronavirus funding

(Sharecast News) - The World Health Organization claims that new loans and bonds could help fill a $28bn funding shortfall for combating the coronavir...

People with severe allergies told to avoid Pfizer-BioNTech Covid vaccine

(Sharecast News) - People who have severe allergies should not receive the Pfizer-BioNTech Covid-19 vaccine, the UK regulator has announced.